Changling Li

Title: Innovations of Changling Li in Analgesic Compounds

Introduction

Changling Li is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel analgesic compounds. His work focuses on creating compounds that can effectively target specific receptors in the body, providing pain relief without the common side effects associated with traditional analgesics.

Latest Patents

Changling Li holds a patent for "Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof." This patent describes compounds represented by a general formula, including their stereoisomers, tautomers, derivatives, prodrugs, or pharmaceutically acceptable salts. These compounds are designed for use in the manufacture of analgesics, specifically targeting muscarine receptors and nicotine acetylcholine receptors. The compounds exhibit a good analgesic effect while minimizing the risk of addiction, making them a promising alternative in pain management.

Career Highlights

Changling Li is affiliated with Peking University, where he conducts research and development in medicinal chemistry. His innovative approach to creating analgesic compounds has positioned him as a key figure in the field. With a focus on improving patient outcomes, his work continues to influence the development of safer pain relief options.

Collaborations

Changling Li collaborates with esteemed colleagues, including Runtao Li and Qi Sun. Their combined expertise enhances the research efforts at Peking University, fostering an environment of innovation and discovery.

Conclusion

Changling Li's contributions to the field of analgesic compounds highlight the importance of innovation in medicine. His patented work represents a significant advancement in pain management, offering new hope for patients seeking effective relief without the risk of addiction.